Coegin Pharma
3.85 SEK
-0.77 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-0.77 %
-1.53 %
-13.29 %
-13.29 %
-50.51 %
-11.49 %
-74.26 %
-85.64 %
-87.90 %
Coegin Pharma is a Swedish biotechnology company in commercial phase, developing science-based innovations for hair and skin. The company's patented ingredient for hair growth is now available in products sold through selected partners. A peptide for natural skin pigmentation is also in development with a planned launch in the near future. Coegin Pharma is headquartered in Lund.
Read moreMarket cap
110.08M SEK
Turnover
25.96K SEK
Revenue
79K
EBIT %
-25,888.61 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
21/5
2026
Interim report Q1'26
21/5
2026
General meeting '26
19/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Coegin Pharma receives first purchase order for new scalp serum
Coegin Pharma accelerates Follicopeptide® portfolio expansion with a new high-performance scalp serum
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools